Understanding IgAN and the associated burden
IgA Nephropathy is the most common form of glomerulonephritis. In the early stages, it causes no, or only very mild, nonspecific symptoms, but it can progress to renal failure over the long term. 25-30% of those with IgA Nephropathy develop end-stage renal disease within 20-25 years.1 Click here for more information on this disease and its impacts on those affected.
What is IgAN?
Gain initial insights into this chronic glomerulonephritis, its main symptoms, its progression and its effects on the kidneys. You will be surprised at the complexity of the disease!
Who can be affected?
How much do you know about the ethnic, geographical, age-related and gender-specific differences in the prevalence of IgA Nephropathy? Learn more about the individuals who are affected by this disease.
How does the disease progress?
Obtain an overview of the characteristic progression of IgA Nephropathy and how the disease is manifested. Click here to learn about the chronological aspects, the factors that can exacerbate the disease and the various clinical phases.
What impact does IgAN have?
Are you aware how living with IgA Nephropathy can impact on the daily lives of those affected? Learn about the emotional and psychosocial consequences of the disease.
- Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int 2021; 100(4S): 1–276.